Royal Bank Of Canada Adc Therapeutics Sa Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Royal Bank Of Canada holds 5,078 shares of ADCT stock, worth $10,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,078
Previous 10,175
50.09%
Holding current value
$10,003
Previous $20,000
65.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ADCT
# of Institutions
84Shares Held
53.9MCall Options Held
5KPut Options Held
7.6K-
Redmile Group, LLC San Francisco, CA15.7MShares$30.9 Million2.32% of portfolio
-
Prosight Management, LP Dallas, TX9.54MShares$18.8 Million4.79% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.97MShares$11.8 Million0.26% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$7 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.02MShares$5.95 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $153M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...